Kashima-gun, Japan

Satoru Kohgo

USPTO Granted Patents = 7 


Average Co-Inventor Count = 3.3

ph-index = 5

Forward Citations = 74(Granted Patents)


Location History:

  • Sendai, JP (2001 - 2002)
  • Kashima-gun, JP (2008 - 2011)

Company Filing History:


Years Active: 2001-2024

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Satoru Kohgo: Innovator in Nucleoside Chemistry

Introduction

Satoru Kohgo is a prominent inventor based in Kashima-gun, Japan. He has made significant contributions to the field of nucleoside chemistry, holding a total of seven patents. His work focuses on developing innovative methods and compounds that have potential applications in medicine.

Latest Patents

Among his latest patents are the "Crosslinked nucleoside intermediate crystal and method for producing same" and the "method for producing crosslinked nucleoside amidite." These inventions involve a crystal of a compound represented by a specific formula, which includes a 4'-C-substituted-2-haloadenosine derivative. The present invention provides a method for producing this derivative, which is useful in the treatment of Acquired Immune Deficiency Syndrome (AIDS). The derivative is combined with a pharmaceutically acceptable carrier to enhance its effectiveness.

Career Highlights

Satoru Kohgo is associated with Yamasa Corporation, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on pharmaceutical applications, particularly in the treatment of serious health conditions.

Collaborations

Some of his notable coworkers include Hiroshi Ohrui and Eiichi Kodama. Their collaborative efforts contribute to the innovative environment at Yamasa Corporation, fostering advancements in nucleoside chemistry.

Conclusion

Satoru Kohgo's contributions to nucleoside chemistry and his innovative patents highlight his role as a key inventor in the field. His work not only advances scientific knowledge but also holds promise for improving medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…